News

News

Pharmacolog selects manufacturing partner

Pharmacolog AB has entered an agreement on a development and production collaboration with UCS Industrial IT AB, involving both mass production and further development of DrugLog®, Pharmacolog’s instrument for quality assurance of clinical intravenous drug handling. This collaboration, which commenced already last year with deliveries of subcomponents for the current DrugLog® product, will fulfil all Pharmacolog’s sourcing needs of complete instruments for both end customers as well as internal users during the next two years. UCS’ competence in production processes will also serve as a basis for future large scale production as well as render shortened lead times in building new prototypes. ”UCS’ skills i...

News

Increased co-operation with HUG

Pharmacolog and the Pharmacy at the University Hospital in Geneva (HUG) have agreed to continue their co-operation to use DrugLog for a broader spectrum of drugs. “There is a need for simple quality control methods for individualized intravenous drugs that can be applied in the routine of a compounding unit and at the point of care. Innovative solutions have to be developed in collaboration between industrial companies and healthcare organizations”, says professor Pascal Bonnabry, head of the hospital pharmacy at the University Hospital in Geneva (HUG). “The results from the first technical and process validations of Pharmacolog’s product, DrugLog, for cytostatic drugs at our department are promising. We w...

News

Pharmacolog article on quality control of IV drug management

Read the complete article here. (Swedish only)

News

First day of trading of the Pharmacolog stock at Aktietorget

Pharmacolog i Uppsala AB is now listed on the Swedish marketplace Aktietorget. As reported earlier Pharmacolog managed to raise 7.5 MSEK in the recently performed share issue.   Starting today, 8 June 2015, the stock is open for trading. Stock code: PHLOG   More information can be found on our page at www.aktietorget.se. aktietorget.se/pharmacolog

News

Pharmacolog strengthens its organization

After having, on a consultancy basis, helped Pharmacolog build its mission to provide secure and better administration of intravenous drugs, primarily for the treatment of cancer, Karl-Erik Carlström and Anders Murman have now been engaged by the company as permanent employees as of June 2015. Karl-Erik assumes the position of Sales and Marketing Manager for Pharmacolog. Karl-Erik has a solid background within international sales and as product manager at several medtech companies such as IBA Particle Therapy from Belgium and Elekta from Sweden. Anders Murman occupies the position of Technical Manager of Pharmacolog, which includes responsibility for the development, production and maintenance of the compa...

News

Nyemissionen avslutad med bra ägarspridning

Pharmacolog i Uppsala AB avslutade den 11 maj nyemissionen som startade i mitten av april 2015. Nyemissionen tecknades till cirka 7,5 MSEK, vilket motsvarar en teckningsgrad om drygt 83 %. Pharmacolog tillförs därmed cirka 6,8 MSEK efter emissionskostnader. Efter emissionen kommer bolaget att ha 290 aktieägare. Komplett pressmeddelande kan laddas ner här som PDF. Pressmeddelande

News

Pharmacolog deltog på Aktiespararnas Aktiedagen

Igår, torsdag den 7 maj, deltog Pharmacologs VD Hans Dahlin och försäljningschef Karl-Erik Carlström på Aktiespararnas Aktiedag som arrangerades på Operaterrassen i Stockholm. Hans Dahlin presenterade bolaget och den pågående emissionen inför noteringen på AktieTorget som avslutas den 11 maj. Karl-Erik Carlström förevisade bolagets färdiga produkt DrugLog och redogjorde för dess marknadspotential. Efter presentationen utfrågades Hans Dahlin och Karl-Erik Carlström av Gunnar Ek från Aktiespararna. Den webb-sända presentationen och utfrågningen finns att se på Internet via länken: http://aktiespararna.media.fnf.nu/33/aktiedagen_2015_stockholm_maj/3

News

Pharmacolog deltar på Sedemera-dagen i Göteborg

Sedemera Fondkomission arrangerar under Tisdagen den 5 Maj ”Sedemera-dagen” i Göteborg. Pharmacolog deltar och presenterar företaget i samband med nyemissionen som just nu pågår. Sista teckningsdag är 11 Maj. Se hela programet för Sedemera-dagen. http://www.sedermeradagen.se/goteborg-2015/dagsschema-goteborg/ Anmälan sker på http://www.sedermeradagen.se/goteborg-2015/ Mer information om nyemissionen hittar du på vår kampanjsida. www.pharmacolog.se/nyemission2015  

News

AktieTorget har godkänt Pharmacologs aktie för notering

Publik nyemission och planerad notering på AktieTorget Teckningstiden för emissionen löper under perioden 13 april – 11 maj 2015. Erbjudandet i sammandrag Teckningstid:                     13 april – 11 maj 2015 Teckningskurs:                  12 kr per aktie Emissionsvolym:               Emissionen uppgår till 9 000 000 kronor fördelat på 750 000 aktier Minsta teckningspost:      500 aktier Marknadsnotering:           Första handelsdagen på AktieTorget beräknas till den 8 juni 2015 Välkommen till informationsträffar Under emissionsperioden genomförs följande informationsträffar där VD Hans Dahlin och ledningsgruppen presenterar bolaget, aktuella framtidsplaner och bakgrunden till emissionen. 9/4 Stockhol...

News

Gunnar Mattson new Chairman of the Board

We welcome Gunnar Mattson who has accepted the position as Chairman of the Board at Pharmacolog. Gunnar has a law degree from the University of Uppsala and has also studied law at the University of Minnesota, USA. He is a member of the Swedish Bar Association since 1994. He is a partner of Advokatfirman Lindahl, one of Sweden’s largest law firms, since 1996. His practice primarily concerns company law, venture capital as well as Swedish and international agreements. Gunnar is very active within pharmaceuticals, biotech, diagnostics and medtech. He was responsible for Lindahl’s practice within life sciences during 2009 – 2014 and is ranked as one of Sweden’s leading lawyers within the sector. He is currentl...